MEDIROM Healthcare Technologies Inc. (MRM) 股票分析

公司概述

MEDIROM Healthcare Technologies Inc. operates within the Consumer Cyclical sector, specifically functioning in the Personal Services industry, where it delivers holistic health services across the Japanese market. The company's operational footprint is segmented into three distinct areas: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty, with its Relaxation Salon segment focused on developing, owning, operating, franchising, and supporting relaxation facilities. In terms of scale, the company currently holds a market capitalization of $8.53M while reporting annual revenue of $8.07B and employing a workforce of 334 individuals. The reported revenue figure of $8.07B, when contrasted against a market cap of only $8.53M, suggests a significant discrepancy between the company's operational scale as measured by sales and its current equity valuation in the stock market.

财务健康

The company reported revenue of $8.07B over the trailing twelve months, with a net income of $40.47M and EBITDA of $149.08M, highlighting a substantial gap between top-line revenue and bottom-line profitability that points to a heavy cost structure or significant non-operating expenses. Despite the positive EBITDA, the entity generated free cash flow of $312.53M, which indicates a robust ability to generate liquidity from operations even before accounting for capital expenditures and debt obligations. The gross margin stands at 25.1%, reflecting the cost of goods sold relative to revenue, while the operating margin is negative at -25.8%, signaling that operating expenses are exceeding gross profit. The profit margin is recorded at 0.5%, further illustrating the challenge in converting revenue into net earnings after all expenses, taxes, and interest. On the balance sheet, the company holds $32.66M in cash but carries a debt load of $3.92B, resulting in a debt-to-equity ratio of 786.42, which characterizes the capital structure as highly leveraged rather than conservative. The current ratio is 0.24, a figure below 1.0 that indicates the company possesses significantly fewer current assets than current liabilities, suggesting potential short-term liquidity constraints. Return on equity is reported at 53.2%, while return on assets is -1.8%, revealing that management is generating high returns on shareholder equity but failing to generate returns on the total asset base.

估值评估

The trailing twelve-month P/E ratio is 2.92, whereas the forward P/E is listed as N/A, implying that the market currently lacks a consensus on future earnings trajectory or that forward estimates are unavailable for this specific security. The price-to-book ratio is 5.57, indicating that the stock trades at a significant premium relative to its book value, which may reflect market expectations for future growth or asset revaluation despite current profitability challenges. Alternative valuation metrics include a price-to-sales ratio of 0.00 and an EV/EBITDA of 27.83, suggesting that the stock's valuation is heavily weighted toward enterprise value relative to earnings rather than sales multiples. The 52-week price range spans from a low of $0.49 to a high of $4.45, and without a specific current price provided in the facts, the trading position relative to this range cannot be precisely quantified beyond the established bounds. The beta is 1.07, which indicates that the stock's price volatility is slightly higher than the broader market average, suggesting a moderate level of systematic risk.

Growth & Income

Revenue growth year-over-year is -6.7%, while earnings growth is N/A, indicating that the company is currently contracting its top line and lacking reported growth in net earnings over the trailing period. Since earnings are N/A and revenue is declining, the relationship between earnings growth and revenue growth cannot be calculated, but the negative revenue trend implies a contraction in the business segment. As a non-dividend payer, the company does not distribute cash to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company retains all earnings rather than paying them out. Consequently, the overall growth and income profile is characterized by negative revenue momentum, high leverage, and a lack of dividend income, with the company relying entirely on internal capital generation and operational restructuring to address its financial position.